ENTITY

Tianjin Zhongxin Phrmctl Gp Cp (600329 CH)

5
Analysis
Health CareChina
Tianjin Zhongxin Pharmaceutical Group Corporation Limited produces and sells traditional Chinese medicine, western medicine, health products, and healthcare instruments. The Group also manufactures gene-related biopharmaceutical products. Tianjin Zhongxin markets its products under the Great Wall, Cypress, and Health brand names.
more
14 Jan 2024 16:11

Quiddity Leaderboard SSE50/180 Jun 24: US$1.3bn One-Way; Some New Names in the Expected Changes List

Collectively, the 5 expected changes for SSE 50 and the 18 expected changes for SSE 180 could generate US$1.3bn in one-way index flows.

Share
25 Feb 2023 04:11

MSCI ACWI Uptrend Break; Defensives to Shine; Ideas in Staples, Health Care, Telecomm, Utilities

$93 on $ACWI has proven to be rock-solid resistance, and it now displays a 4.5-month uptrend violation signaling the pullback has officially begun....

Logo
394 Views
Share
22 Mar 2021 00:00Exchange-sponsored

Singapore Mid-Caps Edge Ahead of Regional Peers in YTD

Singapore’s current crop of 63 Mid-Cap stocks, with a market value between S$1 billion and S$5 billion, have averaged a 12% total return (6%...

Share
bullishGsh Corp Ltd
21 Jan 2021 00:00Exchange-sponsored

Growth Stocks Edge Higher with Value Stocks in Early 2021

Singapore stocks that recently ranked highly for Growth Factor Exposure have kept pace, and been marginally stronger than Value stock...

Share
bullishUOB
29 Dec 2020 00:00Exchange-sponsored

Recent Market Rebound Extended to Value Stocks

Four of the STI’s 10 strongest performers in the 4Q-to-date ranked highly for the Value factors in early 2H20. These four stocks were Jardine...

Share
No more insights
x